Incannex’s Breakthrough Chewing Gum Aids Smoking Cessation
Incannex Healthcare makes breakthrough in smoking cessation drug program as FDA approves clinical trials for CannQuit-N chewing gum.
- Latest
- Trending
Incannex Healthcare makes breakthrough in smoking cessation drug program as FDA approves clinical trials for CannQuit-N chewing gum.
22nd Century Group, Inc. (NASDAQ: XXII) announces major cost cuts in board compensation, aiming to save over $1 million annually ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.